Page 418 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 418

392 Rami N. Al-Rohil and J. Andew Carlson

                                         Prognosis

     There are clinical and histologic predictors of the prognosis of cutaneous vasculitis that
suggest the likelihood of concomitant or later systemic vasculitis [1, 15, 68] as shown in
Table 5.

 Table 5. Clinical, Pathologic, and Laboratory findings indicating a High Probability of
                                             Systemic Disease1

Clinical signs or symptoms                     Suspected Systemic Vasculitis Syndrome

High fever                                     Infection, systemic inflammatory disorders

Paresthesia, foot drop                         EGPA, PAN

Abdominal pain                                 HSP, EGPA, MPA, PAN, RV, LV, BD

Frank arthritis                                RV, infection, PAN, systemic inflammatory

                                               disorder

Hypertension                                   PAN

Purpura above waist, upper extremities         HSP, MPA, GPA, EGPA

> 1 type of vasculitic lesion*                 HSP, MPA, GPA, EGPA, RV, LV, BD

Punctate palmar lesions                        LV

Laboratory evaluation                          Suspected Systemic Vasculitis Syndrome

ESR > 40mm/hr                                  Infection, hematologic malignancies, systemic

                                               inflammatory disorders

Elevated RF, cryoglobulins and low complement CV

Chest x-ray: infiltrates or cavities           GPA (fixed infiltrates), EGPA (non-fixed

                                               infiltrates), MPA, malignancy

Hematuria and/or proteinuria and/or abnormal   Dermal-renal vasculitis syndrome: GPA, MPA,

creatinine                                     HSP, SLE

Hypocomplementemia                             UV associated with SLE, RV, CV, infective

                                               endocarditis

Abnormal blood count                           Infection, hematologic malignancy, systemic

                                               inflammatory disorders

cANCA (PR3)                                    GPA

pANCA (MPO)                                    MPA, EGPA

Eosinophilia, elevated IgE, elevated RF        EGPA

Histologic Examination                         Suspected Systemic Vasculitis Syndrome

Deep dermal and/or subcutaneous small and/or Systemic vasculitis syndrome (GPA, EGPA,

muscular vessel vasculitis                     MPA, CV, BD, RV, LV, septic vasculitis),

                                               malignancy associated

Palisaded neutrophilic (extravascular)         GPA, EGPA, LV, RV

granulomatous dermatitis

Tissue neutrophilia                            SLE, infection

Tissue eosinophilia                            EGPA and drug induced vasculitis

Direct immunofluorescence                      Suspected Systemic Vasculitis Syndrome

Isolated or predominate IgA vascular deposits  HSP

Lupus band (IgG, IgM, and/or C3 at the BMZ)    LV, UV associated with SLE

Abbreviations: BD, Behçet disease; BMZ, basement membrane zone; c-ANCA, cytoplasmic anti-

neutrophil cytoplasmic antibody; CV, cryoglobulinemic vasculitis; EGPA, Eosinophilic

granulomatosis with polyangiitis; ESR, erythrocyte sedimentation rate; GPA, Granulomatosis with

polyangiitis; HSP, Henoch-Schonlein purpura; LV, lupus vasculitis; MPA, microscopic

polyangiitis; MPO, myeloperoxidase; PAN, polyarteritis nodosa; p-ANCA, perinuclear pattern of

anti-neutrophil cytoplasmic antibody; PR-3, antiproteinase-3; RF, rheumatoid factor; RV,

rheumatoid vasculitis; SLE, systemic lupus erythematosus; UV, urticarial vasculitis. Adapted

from [4].

                 Complimentary Contributor Copy
   413   414   415   416   417   418   419   420   421   422   423